Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Journal of Clinical Pharmacology|April 1, 1995
Disposition of phenylbutyrate and its metabolites, phenylacetate and phenylacetylglutamineS C Piscitelli, A Thibault, W D Figg, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 1, 1995
Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: evaluation of three methodsS Alex, S L Gupta, J R Minor, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1999
Safety and efficacy of multilamellar liposomal nystatin against disseminated candidiasis in persistently neutropenic rabbitsA H Groll, V Petraitis, R Petraitiene, et al.
The Journal of Clinical Psychiatry|September 1, 1994
Plasma clozapine and haloperidol concentrations in adolescents with childhood-onset schizophrenia: association with responseS C Piscitelli, J A Frazier, K McKenna, et al.
The Journal of Infectious Diseases|July 7, 2000
Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous systemA H Groll, N Giri, V Petraitis, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbitsA H Groll, D Mickiene, V Petraitis, et al.
Clinical Pharmacology and Therapeutics|December 2, 1998
Pharmacokinetic modeling of recombinant interleukin-2 in patients with human immunodeficiency virus infectionS C Piscitelli, A Forrest, S Vogel, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2001
Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma samplingA H Groll, D Mickiene, R Petraitiene, et al.
Antimicrobial Agents and Chemotherapy|February 27, 1999
A multiple drug interaction study of stavudine with agents for opportunistic infections in human immunodeficiency virus-infected patientsS C Piscitelli, G Kelly, R E Walker, et al.
Antimicrobial Agents and Chemotherapy|September 3, 1999
Pharmacokinetics and safety of high-dose and extended-interval regimens of levofloxacin in human immunodeficiency virus-infected patientsS C Piscitelli, K Spooner, B Baird, et al.
Pageof 8